Cargando…

Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications

Neoadjuvant radio(chemo)therapy is increasingly used in rectal cancer and induces a number of morphologic changes that affect prognostication after curative surgery, thereby creating new challenges for surgical pathologists, particularly in evaluating morphologic changes and tumour response to preop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hav, Monirath, Libbrecht, Louis, Ferdinande, Liesbeth, Geboes, Karen, Pattyn, Piet, Cuvelier, Claude A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609786/ https://www.ncbi.nlm.nih.gov/pubmed/26509160 http://dx.doi.org/10.1155/2015/574540

Ejemplares similares

Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2020)

Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy
por: Yin, Xin-Ke, et al.
Publicado: (2022)

Focus on 16p13.3 Locus in Colon Cancer
por: Mampaey, Evi, et al.
Publicado: (2015)

Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy
por: Rupp, Luise, et al.
Publicado: (2023)

Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer
por: Akiyoshi, T., et al.
Publicado: (2019)

Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery
por: Nardone, Valerio, et al.
Publicado: (2022)

Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma
por: Tostes, Francinne T., et al.
Publicado: (2022)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017)

Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
por: Zhao, Mengjing, et al.
Publicado: (2021)

Carbonic Anhydrase IX Expression and Treatment Response Measured in Rectal Adenocarcinoma Following Neoadjuvant Chemo-Radiotherapy
por: Bádon, Emese Sarolta, et al.
Publicado: (2023)

Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy
por: Wen, Bixiu, et al.
Publicado: (2015)

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
por: Reggiani Bonetti, Luca, et al.
Publicado: (2017)

Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile
por: Meireson, Annabel, et al.
Publicado: (2018)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?
por: Sirohi, Bhawna, et al.
Publicado: (2014)

Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer
por: Bonomo, Pierluigi, et al.
Publicado: (2022)

Does Preoperative Radio(chemo)therapy Increase Anastomotic Leakage in Rectal Cancer Surgery? A Meta-Analysis of Randomized Controlled Trials
por: Qin, Changjiang, et al.
Publicado: (2014)

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
por: De Bruyne, S, et al.
Publicado: (2012)

Neoadjuvant radio-chemotherapy prolongs healing of anastomotic leakage after rectal resection treated with endoscopic vacuum therapy
por: Schiffmann, Leif, et al.
Publicado: (2019)

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report
por: Callebout, Eduard, et al.
Publicado: (2019)

Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer
por: Delitto, Daniel, et al.
Publicado: (2018)

Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer
por: Ren, Dong-Lin, et al.
Publicado: (2019)

Lateral Lymph Node Metastases in Locally Advanced Low Rectal Cancers May Not Be Treated Effectively With Neoadjuvant (Chemo)Radiotherapy Only
por: Haanappel, Anouck, et al.
Publicado: (2019)

Inflammatory myofibroblastic tumor of the distal common bile duct: Literature review with focus on pathological examination
por: Cordier, Fleur, et al.
Publicado: (2023)

Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery
por: Zhao, Jian, et al.
Publicado: (2017)

Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
por: Simonetto, Cristoforo, et al.
Publicado: (2020)

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
por: Glatzer, Markus, et al.
Publicado: (2016)

Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?
por: Montero, Angel, et al.
Publicado: (2022)

Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis
por: Walter, Franziska, et al.
Publicado: (2018)

Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications
por: Alexandrescu, Sorin Tiberiu, et al.
Publicado: (2021)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2017)

Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
por: Zhang, Qi, et al.
Publicado: (2021)

Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer
por: Shin, Jung Kyong, et al.
Publicado: (2022)

Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy
por: Sun, Wenjie, et al.
Publicado: (2016)

Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy
por: Foti, Pietro Valerio, et al.
Publicado: (2016)

Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy
por: Il Yu, Jeong, et al.
Publicado: (2016)

Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells
por: Cheng, Ran, et al.
Publicado: (2019)

Survival benefits of neoadjuvant chemo(radio)therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis
por: Pan, Long, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mh02mbftdeduf787q2o1usf9aa